Endocannabinoids and immune regulation

被引:180
作者
Pandey, Rupal [1 ]
Mousawy, Khalida [1 ]
Nagarkatti, Mitzi [1 ]
Nagarkatti, Prakash [1 ]
机构
[1] Univ S Carolina, Dept Pathol Microbiol & Immunol, Sch Med, Columbia, SC 29209 USA
关键词
Endocannabinoids; Immune response; ENDOGENOUS CANNABINOID SYSTEM; KILLER CELL-ACTIVITY; MAST-CELLS; IN-VIVO; NITRIC-OXIDE; RECEPTOR-LIGAND; DENDRITIC CELLS; GLIOMA-CELLS; CANCER-CELLS; TUMOR-GROWTH;
D O I
10.1016/j.phrs.2009.03.019
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Cannabinoid pharmacology has made important advances in recent years after the discovery of the cannabinoid receptors. These discoveries have added to our understanding of exogenous and endogenous cannabinoid signaling along with exploring the various pathways of their biosynthesis, molecular structure, inactivation, and anatomical distribution of their receptors throughout the body. The endocannabinoid system is involved in immunoregulation and neuroprotection. In this article, we have reviewed the possible mechanisms of the regulation of the immune response by endocannabinoids which include modulation of immune response in different cell types, effect on cytokine network, induction of apoptosis in immune cells and downregulation of innate and adaptive immune response. Studies from our laboratory have suggested that administration of endocannabinoids or use of inhibitors of enzymes that breakdown the endocannabinoids, leads to immunosuppression and recovery from immune-mediated injury to organs such as the liver. Thus, manipulation of endocannabinoids in vivo may constitute a novel treatment modality against inflammatory disorders. (C) 2009 Published by Elsevier Ltd.
引用
收藏
页码:85 / 92
页数:8
相关论文
共 98 条
[1]
Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis [J].
Achiron, A ;
Miron, S ;
Lavie, V ;
Margalit, R ;
Biegon, A .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 102 (01) :26-31
[2]
Functional role of high-affinity anandamide transport, as revealed by selective inhibition [J].
Beltramo, M ;
Stella, N ;
Calignano, A ;
Lin, SY ;
Makriyannis, A ;
Piomelli, D .
SCIENCE, 1997, 277 (5329) :1094-1097
[3]
BERDYSHEV EV, 2000, J PHARMACOL EXP THER, V293, P136
[4]
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation [J].
Bifulco, M ;
Laezza, C ;
Valenti, M ;
Ligresti, A ;
Portella, G ;
Di Marzo, V .
FASEB JOURNAL, 2004, 18 (11) :1606-+
[5]
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth [J].
Bifulco, M ;
Laezza, C ;
Portella, G ;
Vitale, M ;
Orlando, P ;
De Petrocellis, L ;
Di Marzo, V .
FASEB JOURNAL, 2001, 15 (12) :2745-+
[6]
Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes [J].
Bisogno, T ;
Maurelli, S ;
Melck, D ;
DePetrocellis, L ;
DiMarzo, V .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (06) :3315-3323
[7]
Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas [J].
Blázquez, C ;
González-Feria, L ;
Alvarez, L ;
Haro, A ;
Casanova, ML ;
Guzmán, M .
CANCER RESEARCH, 2004, 64 (16) :5617-5623
[8]
Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro [J].
Bueb, JL ;
Lambert, DM ;
Tschirhart, EJ .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2001, 1538 (2-3) :252-259
[9]
ANANDAMIDE INHIBITS MACROPHAGE-MEDIATED KILLING OF TUMOR NECROSIS FACTOR-SENSITIVE CELLS [J].
CABRAL, GA ;
TONEY, DM ;
FISCHERSTENGER, K ;
HARRISON, MP ;
MARCIANOCABRAL, F .
LIFE SCIENCES, 1995, 56 (23-24) :2065-2072
[10]
Δ9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation [J].
Caffarel, Maria M. ;
Sarrio, David ;
Palacios, Jose ;
Guzman, Manuel ;
Sanchez, Cristina .
CANCER RESEARCH, 2006, 66 (13) :6615-6621